Co-localization of COX-2, CYP4F8, and mPGES-1 in epidermis with prominent expression of CYP4F8 mRNA in psoriatic lesions

Prostaglandins and Other Lipid Mediators

Volumn 79, Issue 1-2, 2006, Pages 114-125

  Stark, Katarina ^a   Törmä, Hans ^b   Oliw, Ernst H ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

19 Hydroxyprostaglandins; All trans retinoic acid; Arachidonic acid metabolism; Immunohistochemistry; Inflammation; Phorbol ester; Real time RT PCR

Indexed keywords

CYCLOOXYGENASE 2; CYTOCHROME P450; CYTOCHROME P450 F8; MESSENGER RNA; MICROSOMAL PROSTAGLANDIN SYNTHASE 1; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN SYNTHASE; RETINOIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME LOCALIZATION; EPIDERMIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LIPID OXIDATION; MALE; PSORIASIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY; WESTERN BLOTTING;

ARYL HYDROCARBON HYDROXYLASES; CARCINOGENS; CELL LINE; CYCLOOXYGENASE 2; CYTOKINES; EPIDERMIS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INFLAMMATION; INTRAMOLECULAR OXIDOREDUCTASES; KERATINOCYTES; MEMBRANE PROTEINS; PSORIASIS; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE;

EID: 33644558369     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2005.12.003     Document Type: Article

References (46)

1. M.P. Schön, and W.H. Boehncke Psoriasis N Engl J Med 352 2005 1899
2. V.A. Ziboh, Y. Cho, I. Mani, and S. Xi Biological significance of essential fatty acids/prostanoids/lipoxygenase-derived monohydroxy fatty acids in the skin Arch Pharm Res 25 2002 747
3. C.D. Funk Prostaglandins and leukotrienes: advances in eicosanoid biology Science 294 2001 1871
4. W.L. Smith, and I. Song The enzymology of prostaglandin endoperoxide H synthases-1 and -2 Prostaglandins Other Lipid Mediat 68-69 2002 115
5. J. Leong, M. Hughes-Fulford, and N. Rakhlin Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation Exp Cell Res 224 1996 79
6. P. Patrignani, S. Tacconelli, M.G. Sciulli, and M.L. Capone New insights into COX-2 biology and inhibition Brain Res Brain Res Rev 48 2005 352
7. C.S. Tripp, E.A. Blomme, and K.S. Chinn Epidermal COX-2 induction following ultraviolet irradiation: suggested mechanism for the role of COX-2 inhibition in photoprotection J Invest Dermatol 121 2003 853
8. G. Smith, R.S. Dawe, and C. Clark Quantitative real-time reverse transcription-polymerase chain reaction analysis of drug metabolizing and cytoprotective genes in psoriasis and regulation by ultraviolet radiation J Invest Dermatol 121 2003 390
9. N. Ueno, Y. Takegoshi, D. Kamei, I. Kudo, and M. Murakami Coupling between cyclooxygenases and terminal prostanoid synthases Biochem Biophys Res Commun 338 2005 70
10. E.H. Oliw Oxygenation of polyunsaturated fatty acids by cytochrome P450 monooxygenases Prog Lipid Res 33 1994 329
11. D.W. Nebert, and D.W. Russell Clinical importance of the cytochromes P450 Lancet 360 2002 1155
12. N. Ahmad, and H. Mukhtar Cytochrome p450: a target for drug development for skin diseases J Invest Dermatol 123 2004 417
13. H.I. Swanson Cytochrome P450 expression in human keratinocytes: an aryl hydrocarbon receptor perspective Chem Biol Interact 149 2004 69
14. L. Du, S.M. Hoffman, and D.S. Keeney Epidermal CYP2 family cytochromes P450 Toxicol Appl Pharmacol 195 2004 278
15. D.E. Prosser, and G. Jones Enzymes involved in the activation and inactivation of vitamin D Trends Biochem Sci 29 2004 664
16. G. Smith, C.R. Wolf, and Y.Y. Deeni Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases Lancet 361 2003 1336
17. J.A. White, B. Beckett-Jones, and Y.D. Guo cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450 J Biol Chem 272 1997 18538
18. Y. Kikuta, E. Kusunose, and M. Kusunose Prostaglandin and leukotriene omega-hydroxylases Prostaglandins Other Lipid Mediat 68-69 2002 345
19. M.C. Gonzalez, C. Marteau, J. Franchi, and D. Migliore-Samour Cytochrome P450 4A11 expression in human keratinocytes: effects of ultraviolet irradiation Br J Dermatol 145 2001 749
20. K. Stark, H. Törmä, M. Cristea, and E.H. Oliw Expression of CYP4F8 (prostaglandin H 19-hydroxylase) in human epithelia and prominent induction in epidermis of psoriatic lesions Arch Biochem Biophys 409 2003 188
21. D. Richter-Hintz, R. Their, and S. Steinwachs Allelic variants of drug metabolizing enzymes as risk factors in psoriasis J Invest Dermatol 120 2003 765
22. J. Bylund, M. Hidestrand, M. Ingelman-Sundberg, and E.H. Oliw Identification of CYP4F8 in human seminal vesicles as a prominent 19-hydroxylase of prostaglandin endoperoxides J Biol Chem 275 2000 21844
23. P.J. Jakobsson, S. Thorén, R. Morgenstern, and B. Samuelsson Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target Proc Natl Acad Sci USA 1999 7220
24. M. Murakami, H. Naraba, and T. Tanioka Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2 J Biol Chem 275 2000 32783
25. K. Stark, J. Bylund, H. Törmä, G. Sahlén, and E.H. Oliw On the mechanism of biosynthesis of 19-hydroxyprostaglandins of human seminal fluid and expression of cyclooxygenase-2, PGH 19-hydroxylase (CYP4F8) and microsomal PGE synthase-1 in seminal vesicles and vas deferens Prostaglandins Other Lipid Mediat 75 2005 47
26. R.W. Kelly Immunomodulators in human seminal plasma: a vital protection for spermatozoa in the presence of infection? Int J Androl 22 1999 2
27. M. Lazarus, C.J. Munday, and N. Eguchi Immunohistochemical localization of microsomal PGE synthase-1 and cyclooxygenases in male mouse reproductive organs Endocrinology 143 2002 2410
28. K. Stark, B. Wongsud, R. Burman, and E.H. Oliw Oxygenation of polyunsaturated long chain fatty acids by recombinant CYP4F8 and CYP4F12 and catalytic importance of Tyr-125 and Gly-328 of CYP4F8 Arch Biochem Biophys 441 2005 174
29. C.E. Griffiths, L.J. Finkel, M.G. Tranfaglia, T.A. Hamilton, and J.J. Voorhees An in vivo experimental model for effects of topical retinoic acid in human skin Br J Dermatol 129 1993 389
30. J. Bylund, N. Finnström, and E.H. Oliw Gene expression of a novel cytochrome P450 of the CYP4F subfamily in human seminal vesicles Biochem Biophys Res Commun 261 1999 169
31. J. Bylund, M. Bylund, and E.H. Oliw cDNA cloning and expression of CYP4F12, a novel human cytochrome P450 Biochem Biophys Res Commun 280 2001 892
32. M. Nishimura, H. Yaguti, H. Yoshitsugu, S. Naito, and T. Satoh Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR Yakugaku Zasshi 123 2003 369
33. H. Törmä, T. Karlsson, G. Michaelsson, O. Rollman, and A. Vahlquist Decreased mRNA levels of retinoic acid receptor alpha, retinoid X receptor alpha and thyroid hormone receptor alpha in lesional psoriatic skin Acta Derm Venereol 80 2000 4
34. K. Stark, L. Schauer, G.E. Sahlén, G. Ronquist, and E.H. Oliw Expression of CYP4F12 in gastrointestinal and urogenital epithelia Basic Clin Pharmacol Toxicol 94 2004 177
35. C.R. Denz, and D.K. Dube The benefits of 28S rRNA for standardization of reverse transcription-polymerase chain reaction for studying gene expression Anal Biochem 341 2005 382
36. D.F. Woodward, C.E. Protzman, A.H. Krauss, and L.S. Williams Identification of 19 (R)-OH prostaglandin E2 as a selective prostanoid EP2-receptor agonist Prostaglandins 46 1993 371
37. J.W. Regan EP2 and EP4 prostanoid receptor signaling Life Sci 74 2003 143
38. R.L. Konger, R. Malaviya, and A.P. Pentland Growth regulation of primary human keratinocytes by prostaglandin E receptor EP2 and EP3 subtypes Biochim Biophys Acta 1401 1998 221
39. J. Akaogi, H. Yamada, and Y. Kuroda Prostaglandin E2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-alpha and IL-6 production J Leukoc Biol 76 2004 227
40. M. Wolters Diet and psoriasis: experimental data and clinical evidence Br J Dermatol 153 2005 706
41. D.S. Keeney, C. Skinner, S. Wei, T. Friedberg, and M.R. Waterman A keratinocyte-specific epoxygenase, CYP2B12, metabolizes arachidonic acid with unusual selectivity, producing a single major epoxyeicosatrienoic acid J Biol Chem 273 1998 9279
42. D.S. Keeney, C. Skinner, and J.B. Travers Differentiating keratinocytes express a novel cytochrome P450 enzyme, CYP2B19, having arachidonate monooxygenase activity J Biol Chem 273 1998 32071
43. P.A. Ladd, L. Du, J.H. Capdevila, R. Mernaugh, and D.S. Keeney Epoxyeicosatrienoic acids activate transglutaminases in situ and induce cornification of epidermal keratinocytes J Biol Chem 278 2003 35184
44. Y. Kikuta, Y. Yamashita, and S. Kashiwagi Expression and induction of CYP4F subfamily in human leukocytes and HL60 cells Biochim Biophys Acta 1683 2004 7
45. Y. Mizukami, H. Sumimoto, and K. Takeshige Induction of cytochrome CYP4F3A in all-trans-retinoic acid-treated HL60 cells Biochem Biophys Res Commun 314 2004 104
46. V.D. Marinescu, I.S. Kohane, and A. Riva The MAPPER database: a multi-genome catalog of putative transcription factor binding sites Nucleic Acids Res 33 2005 D91